Yes and No. The board was effusive on that matter...I guess as they have to be.
I do not expect a capital raising to be announced tomorrow (like last year) but there are no guarantees. The Chairman did chime in to help with capital type questions and the feeling that I got was that after CE Mark was granted that the Board would seriously consider the capital raising issue, particularly whether to raise capital to undertake the FDA trial sooner rather than later or to wait and fund it from retained earnings.
Scott
TIS Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held